Published in Gynecol Oncol on June 01, 1997
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol (2007) 2.17
Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma. Gynecol Oncol (2011) 1.49
Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. Cochrane Database Syst Rev (2011) 0.91
Outcome analysis in patients with uterine sarcoma. Radiat Oncol J (2015) 0.80
Tamoxifen in breast cancer ipse dixit in uterine malignant mixed Müllerian tumor and sarcoma-A report of 8 cases and review of the literature. Rep Pract Oncol Radiother (2013) 0.80
F-18 fluorodeoxyglucose positron emission tomography/computed tomography in a rare case of recurrent malignant mixed mullerian tumor. World J Nucl Med (2014) 0.78
Uterine carcinosarcomas: 8-year single center experience of 25 cases. Indian J Med Paediatr Oncol (2011) 0.78
Clinical Characteristics, Surgical Management and Adjuvant Therapy of Patients with Uterine Carcinosarcoma: A Retrospective Case Series. Geburtshilfe Frauenheilkd (2016) 0.76
The reasonable timing of the adjuvant radiotherapy in the treatment of uterine carcinosarcoma according to the surgical intent: suggestion based on progression patterns. Radiat Oncol J (2013) 0.75
A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma. Gynecol Oncol (2015) 0.75
Terminology in gynaecological cytopathology: report of the Working Party of the British Society for Clinical Cytology. J Clin Pathol (1986) 5.76
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA (2000) 3.69
Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. J Clin Pathol (1966) 2.99
A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol (1989) 2.71
Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg (1981) 1.90
Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys (1999) 1.81
Current views on cervical intraepithelial neoplasia. J Clin Pathol (1991) 1.72
Management of women with abnormal cervical smears: supplement to terminology in gynaecological cytopathology. J Clin Pathol (1987) 1.61
Predictors of recurrence in stage I (T1N0M0) breast carcinoma. Ann Surg (1981) 1.60
Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX. Cell (1987) 1.60
Paclitaxel-based chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol (2001) 1.59
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol (1989) 1.57
Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology. Eur J Cancer (1994) 1.54
Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential. Gynecol Oncol (1995) 1.54
Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE Trial.A Stent vs. Stent Ultrasound Remodeling Evaluation. J Am Coll Cardiol (2001) 1.52
Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am J Pathol (1993) 1.50
Advances in 4D medical imaging and 4D radiation therapy. Technol Cancer Res Treat (2008) 1.45
Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma. Obstet Gynecol (1988) 1.45
Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease. Gynecol Oncol (1998) 1.42
Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys (2001) 1.42
Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer (2000) 1.41
Impact of conventional and three-dimensional thallium-technetium scans on surgery for primary hyperparathyroidism. J R Soc Med (1990) 1.41
The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2000) 1.38
HIV/AIDS policies and sports: the National Football League. Med Sci Sports Exerc (1994) 1.38
Membrane potential defect in hygromycin B-resistant pma1 mutants of Saccharomyces cerevisiae. J Biol Chem (1988) 1.38
Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes. Cancer (2000) 1.24
Soft-tissue sarcoma of the vagina and vulva: a clinicopathologic study. Obstet Gynecol (1995) 1.21
Primary malignant tumours of the thyroid: the relationship between histological classification and clinical behaviour. Br J Surg (1976) 1.19
Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. J Clin Oncol (2000) 1.19
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer (2008) 1.18
Prognosis in stage II (T1N1M0) breast cancer. Ann Surg (1981) 1.16
Mucin production in medullary carcinoma of the thyroid. Arch Pathol Lab Med (1983) 1.13
Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers. Cancer Res (1998) 1.10
ACTH, glucagon and gastrin production by a pancreatic islet cell carcinoma and its treatment. Clin Endocrinol (Oxf) (1973) 1.08
Treatment of endometrial stromal tumors. Gynecol Oncol (1990) 1.08
Report of a family with inherited medullary carcinoma of the thyroid and phaeochromocytoma. Br J Surg (1975) 1.05
Angiotensin II type 1 receptor expression in human breast tissues. Br J Cancer (1997) 1.04
Bacterial ureases in uraemic men. Lancet (1971) 1.02
Carcinogenic effects of radiotherapy for breast cancer. Oncology (Williston Park) (1999) 1.02
Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. Gynecol Oncol (2013) 0.99
Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Br J Cancer (1999) 0.99
Thyroid cancer in young patients in Great Britain. Br J Surg (1974) 0.98
Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study. Am J Clin Pathol (1985) 0.97
High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys (1998) 0.97
Serum cardiac troponin T levels during treatment of early-stage breast cancer. J Clin Oncol (1995) 0.96
A test of the carcinogenicity of enflurane, isoflurane, halothane, methoxyflurane, and nitrous oxide in mice. Anesth Analg (1979) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecol Oncol (1991) 0.95
Treatment of uterine leiomyosarcoma. Obstet Gynecol (1988) 0.95
The application of immunohistochemical stains to identify endothelial-lined channels in mammary carcinoma. Cancer (1987) 0.95
Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol (1993) 0.94
Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin. J Biol Chem (1998) 0.94
Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogenes in human thyroid neoplasia. Eur J Cancer (1990) 0.94
Meningitis in Whipple's disease. Br Med J (1978) 0.93
Smears diagnosed as ASCUS: interobserver variation and follow-up. Diagn Cytopathol (2001) 0.92
Lung function in prematurely delivered rabbits treated with a synthetic surfactant. Am Rev Respir Dis (1987) 0.91
Immunohistochemical localization of P-glycoprotein in adult human ovary and female genital tract of patients with benign gynecological conditions. J Histochem Cytochem (1990) 0.91
The effects of substance P and related peptides on alpha-amylase release from rat parotid gland slices. Br J Pharmacol (1981) 0.91
Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog (1991) 0.91
Prognostic factors in adenocarcinoma of the uterine cervix. Cancer (1986) 0.90
Utilisation of ketoacid analogues of valine and phenylalanine in health and uraemia. Lancet (1972) 0.90
Ovarian cytology. An application of cytology in an attempt at the early detection of ovarian carcinoma. Br J Cancer (1971) 0.90
Follicular carcinoma. Semin Diagn Pathol (1985) 0.90
Exocrine pancreatic function studies, duodenal cytology, and hypotonic duodenography in the diagnosis of surgical jaundice. Lancet (1972) 0.89
Pap smears in women with endometrial carcinoma. Acta Cytol (2001) 0.89
Mammary carcinoma with "choriocarcinomatous" features. Am J Surg Pathol (1981) 0.89
Abnormalities of the EGF receptor system in human thyroid neoplasia. Int J Cancer (1991) 0.88
Prognostic factors in advanced ovarian carcinoma. J Clin Oncol (1986) 0.88
Randomized clinical trial into the impact of rigid foot orthoses on balance parameters in excessively pronated feet. Clin Rehabil (2004) 0.88
Solution conformation of the antitumor drug streptonigrin. J Med Chem (1993) 0.88
Synthesis of phenylalanine and valine by healthy and uraemic men. Lancet (1971) 0.88
Entry of thyroid hormones into tilapia oocytes. Comp Biochem Physiol B Biochem Mol Biol (2001) 0.88
Bovine viral diarrhea infection in pigs. J Am Vet Med Assoc (1971) 0.87
Introduction to PCR/OLA/SCS, a multiplex DNA test, and its application to cystic fibrosis. Genet Test (1997) 0.87
The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol Oncol (1997) 0.87
Colorectal metastases to the liver: selective chemoembolization. Radiology (1993) 0.86
Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression. Int J Cancer (1999) 0.86
A new DNA-dependent ATPase from Escherichia coli. Purification and characterization of ATPase IV. J Biol Chem (1984) 0.86
Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study Group. Am J Cardiol (1992) 0.86
Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases. Obstet Gynecol (1992) 0.86
Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers. Int J Radiat Oncol Biol Phys (2001) 0.86
Coxsackievirus B4 infection of the mouse pancreas: acute and persistent infection. J Gen Virol (1992) 0.85
Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo. Pediatr Res (1995) 0.85
The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecol Oncol (2001) 0.85
Laparotomy to complete staging of presumed early ovarian cancer. Obstet Gynecol (1996) 0.85
Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol (1991) 0.84
Angiolymphoid hyperplasia with eosinophilia in the colon: a novel cause of rectal bleeding. J Clin Pathol (1997) 0.84
Spatial and temporal variations in silver contamination and toxicity in San Francisco Bay. Environ Res (2007) 0.83
Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential. Gynecol Oncol (1989) 0.83
Effect of streptozotocin on qualitative aspects of plasma insulin in a patient with a malignant islet cell tumor. J Clin Endocrinol Metab (1970) 0.83
Identification of structurally distinct catalytic intermediates of the H+-ATPase from yeast plasma membranes. J Biol Chem (1987) 0.83
Changes in plasma vitellogenin, sex steroids, calcitonin, and thyroid hormones related to sexual maturation in female brown trout (Salmo trutta). Gen Comp Endocrinol (1989) 0.83
Congenital dilation of the intrahepatic bile ducts. Am J Med (1966) 0.82
Diagnosis and treatment of patients with gastroesophageal reflux and noncardiac chest pain. South Med J (1994) 0.82
Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer. Gynecol Oncol (1993) 0.82
Pathology of the cold nodule. Clin Endocrinol Metab (1981) 0.82
Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli. Am J Surg Pathol (1982) 0.82
Primary gastric choriocarcinoma. An immunohistological study. Am J Surg Pathol (1981) 0.81